Welcome to the Psychedelic Rundown, a New Series By Psychedelic Profits Created to Help Investors Cut Through the Market Noise...
The article PsyCap Recap: 3 Key Takeaways from MindBio’s Presentation at Psychedelic Capital was originally published on Microdose. Microdosing has...
As our ancestors foraged for mushrooms or drank beer made from ergot-infested barley, they stumbled upon substances that can have the most profound effect...
CaaMTech, a Seattle-area startup developing new psychedelic agents, has raised $22 million in funding, the company announced this week. The company is...
As psychedelic-assisted therapies enter the medical and pharmaceutical mainstream, some scientists are pushing back against a mystical mindset that permeates...
The article Why Aren’t Psychedelics Addictive? An Evidence-Based Review was originally published on Microdose. A 2015 peer-reviewed study in the Journal...
In August, Canada’s federal government announced an early election for the coming month, giving psychedelic advocates renewed incentive to campaign for...
The bill, SB 519, is on hold to allow a coalition of supporters to build support for the bill among legislators. The post What Is the...
One year ago, Ann Arbor, Michigan made history by decriminalizing psychedelic plants and fungi. Now, while the city is gearing up to observe its first...
The article Psychedelic Titans with Erin Cochrane of Gwella was originally published on Microdose. This week's Psychedelic Titan is Erin Cochrane, Co-founder...
